A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)
Clinical trial NCT01183858 · COMPLETED
Trial details
- NCT number
- NCT01183858
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.